We previously reported that Cp undergoes oxidative modifications in the CSF of Parkinson’s disease (PD) and Alzheimer’s disease (AD) patients [6], due to the oxidative environment of pathological CSF [7,8]. The gene discussed is CP; the disease is Alzheimer disease.